| Stage | MATX | % of rev | VNT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $969M | 100.00% | $757M | 100.00% | MATX ×1.28 |
| Gross profit | $232M | 23.94% | $365M | 48.24% | VNT +24.3pp |
| Operating income | $159M | 16.39% | $147M | 19.39% | VNT +3.0pp |
| Pre-tax income | $164M | 16.91% | $44M | 5.79% | MATX +11.1pp |
| Net income | $129M | 13.35% | $27M | 3.62% | MATX +9.7pp |
| Stage | MATX | VNT | Gap · A − B |
|---|---|---|---|
| Revenue | $969M100.00% | $757M100.00% | MATX ×1.28 |
| Gross profit | 23.94%$232M | 48.24%$365M | VNT +24.3pp |
| Operating income | 16.39%$159M | 19.39%$147M | VNT +3.0pp |
| Pre-tax income | 16.91%$164M | 5.79%$44M | MATX +11.1pp |
| Net income |
| 13.35%$129M |
| 3.62%$27M |
| MATX +9.7pp |
None
No disclosed counterparties: MATX.